HTGF, Bayern Kapital back medineering

The cash injection will be used to develop and refine medineering's products, which it intends to bring to market in the near future.

The venture backers were joined by a consortium of business angels. The investors stated their decision to invest was based on the high demand they expected for medineering's product portfolio, which aims to improve efficiency in operating theatres.

Bayern Kapital highlighted the fact that medineering's products are specifically tailored to head surgery, unlike their competitors.

According to medineering, the market for computer-aided surgery will exceed $24bn in 2014, while the endoscopic head surgery market is forecast to reach almost $5bn in 2016.

Born2Grow is a Heilbronn-based venture capital fund founded in 2013. It invests up to €500,000 in early-stage high-tech companies to allow them to bring their products to market.

Company
Headquartered in Munich, medineering is a medical technology company specialising in robotic systems for head surgery. The product portfolio comprises a modular set of passive and active surgical manipulators, which vary by surgical requirements and price.

The products enable surgeons to use both hands when operating, as the robotic parts are used for holding and positioning medical instruments, such as the endoscope. Surgical processes are made less invasive for patients and more efficient, saving up to 20% of the time taken for procedures without the instruments, the company says.

The company stated it would become possible for brain tumours to be removed through the nose, as the need for invasive surgery would be reduced.

People
Stephan Nowatschin is CEO and co-founder of medineering with Maximilian Krinninger. Sebastian Schöfer is investment manager at HTGF. Bernd Schafberger is investment manager at Bayern Kapital.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• DACH
• Early-stage
• Healthcare
• Germany
• High-Tech Gründerfonds